Why the study?
Although percutaneous coronary intervention for chronic total occlusion has achieved high success rates and acceptable safety outcomes, its survival benefits remain debated.
Does successful percutaneous coronary intervention for chronic total occlusion reduce all-cause death compared to failed recanalization in patients with native coronary vessel CTO?
Does successful percutaneous coronary intervention for chronic total occlusion reduce all-cause death compared to failed recanalization in patients with native coronary vessel CTO?
Answers are grounded in this paper and cite their sources.
Over a 12-year follow-up, successful CTO-PCI did not confer a long-term survival benefit or reduction in myocardial infarction compared to failed CTO-PCI, with adverse clinical outcomes largely driven by baseline patient comorbidities.
BACKGROUND: Over decades of advancement, percutaneous coronary intervention (PCI) for chronic total occlusion (CTO) has achieved high success rates and acceptable safety outcomes. However, the survival benefits of CTO-PCI are still debated. AIMS: To understand the clinical benefit of CTO-PCI better, we present the 12-year follow-up results of a prospective CTO registry study, with the aim of describing the clinical course according to patients' risk characteristics. METHODS: Between March 2003 and February 2015, 1219 consecutive patients with CTO of native coronary vessels requiring PCI were enrolled. Among them, CTO-PCI was successful in 1047 patients (85.9%). The primary outcome of this study was all-cause death at maximum available follow-up between patients with successful and failed CTO recanalization. RESULTS: During the median follow-up of 12.1 years, all-cause death was not significant difference between the CTO-PCI success group and the CTO-PCI failure group (15.6% vs. 18.0% at 12 years, p = 0.69). In multivariable analysis for the primary outcome, the failure of CTO-PCI was not an independent risk factor for all-cause death (adjusted hazard ratio 0.842; p = 0.302) or myocardial infarction (adjusted hazard ratio 0.667; p = 0.345). Independent predictors of all-cause death included diabetes, previous history of myocardial infarction, heart failure, or chronic kidney disease. CONCLUSION: Compared with successful PCI for CTO, failed PCI for CTO was not associated with a higher long-term risk of all-cause death or myocardial infarction. Adverse clinical characteristics were an independent predictor of adverse clinical outcomes.
No takes yet. Share an insight, caveat, or question.
Park et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: